146 related articles for article (PubMed ID: 16344012)
1. Synergism of Leu-Lys rich antimicrobial peptides and chloramphenicol against bacterial cells.
Park Y; Park SN; Park SC; Shin SO; Kim JY; Kang SJ; Kim MH; Jeong CY; Hahm KS
Biochim Biophys Acta; 2006 Jan; 1764(1):24-32. PubMed ID: 16344012
[TBL] [Abstract][Full Text] [Related]
2. A Leu-Lys-rich antimicrobial peptide: activity and mechanism.
Park Y; Lee DG; Jang SH; Woo ER; Jeong HG; Choi CH; Hahm KS
Biochim Biophys Acta; 2003 Feb; 1645(2):172-82. PubMed ID: 12573247
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial synergism of novel antibiotic peptides with chloramphenicol.
Park Y; Kim HJ; Hahm KS
Biochem Biophys Res Commun; 2004 Aug; 321(1):109-15. PubMed ID: 15358222
[TBL] [Abstract][Full Text] [Related]
4. Antibiotic activity of Leu-Lys rich model peptides.
Park Y; Lee DG; Hahm KS
Biotechnol Lett; 2003 Aug; 25(16):1305-10. PubMed ID: 14514057
[TBL] [Abstract][Full Text] [Related]
5. Structural flexibility and the positive charges are the key factors in bacterial cell selectivity and membrane penetration of peptoid-substituted analog of Piscidin 1.
Kim JK; Lee SA; Shin S; Lee JY; Jeong KW; Nan YH; Park YS; Shin SY; Kim Y
Biochim Biophys Acta; 2010 Oct; 1798(10):1913-25. PubMed ID: 20603100
[TBL] [Abstract][Full Text] [Related]
6. Effects of Pro --> peptoid residue substitution on cell selectivity and mechanism of antibacterial action of tritrpticin-amide antimicrobial peptide.
Zhu WL; Lan H; Park Y; Yang ST; Kim JI; Park IS; You HJ; Lee JS; Park YS; Kim Y; Hahm KS; Shin SY
Biochemistry; 2006 Oct; 45(43):13007-17. PubMed ID: 17059217
[TBL] [Abstract][Full Text] [Related]
7. Effective antimicrobial activity of a peptide mutant Cbf-14-2 against penicillin-resistant bacteria based on its unnatural amino acids.
Kang W; Liu H; Ma L; Wang M; Wei S; Sun P; Jiang M; Guo M; Zhou C; Dou J
Eur J Pharm Sci; 2017 Jul; 105():169-177. PubMed ID: 28522372
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of novel in silico-developed antimicrobial peptides against a panel of bacterial pathogens.
Romani AA; Baroni MC; Taddei S; Ghidini F; Sansoni P; Cavirani S; Cabassi CS
J Pept Sci; 2013 Sep; 19(9):554-65. PubMed ID: 23893489
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic and synergistic effect of Leu-Lys rich peptide against antibiotic resistant microorganisms isolated from patients with cholelithiasis.
Jeong N; Kim JY; Park SC; Lee JK; Gopal R; Yoo S; Son BK; Hahm JS; Park Y; Hahm KS
Biochem Biophys Res Commun; 2010 Sep; 399(4):581-6. PubMed ID: 20682287
[TBL] [Abstract][Full Text] [Related]
10. Novel Hybrid Peptide Cecropin A (1-8)-LL37 (17-30) with Potential Antibacterial Activity.
Wei XB; Wu RJ; Si DY; Liao XD; Zhang LL; Zhang RJ
Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27367675
[TBL] [Abstract][Full Text] [Related]
11. Bestowing antifungal and antibacterial activities by lipophilic acid conjugation to D,L-amino acid-containing antimicrobial peptides: a plausible mode of action.
Avrahami D; Shai Y
Biochemistry; 2003 Dec; 42(50):14946-56. PubMed ID: 14674771
[TBL] [Abstract][Full Text] [Related]
12. Design of potent, non-toxic antimicrobial agents based upon the naturally occurring frog skin peptides, ascaphin-8 and peptide XT-7.
Conlon JM; Galadari S; Raza H; Condamine E
Chem Biol Drug Des; 2008 Jul; 72(1):58-64. PubMed ID: 18554256
[TBL] [Abstract][Full Text] [Related]
13. Rational design of mirror-like peptides with alanine regulation.
Li W; Tan T; Xu W; Xu L; Dong N; Ma D; Shan A
Amino Acids; 2016 Feb; 48(2):403-17. PubMed ID: 26385363
[TBL] [Abstract][Full Text] [Related]
14. Membrane interactions of designed cationic antimicrobial peptides: the two thresholds.
Glukhov E; Burrows LL; Deber CM
Biopolymers; 2008 May; 89(5):360-71. PubMed ID: 18186149
[TBL] [Abstract][Full Text] [Related]
15. Influence of the N- and C-terminal regions of leu-lys rich antimicrobial peptide on antimicrobial activity.
Park HK; Lim HT; Chae BJ; Hahm KS; Park Y
Protein Pept Lett; 2008; 15(2):188-92. PubMed ID: 18289109
[TBL] [Abstract][Full Text] [Related]
16. Design of novel analogue peptides with potent fungicidal but low hemolytic activity based on the cecropin A-melittin hybrid structure.
Lee DG; Park JH; Shin SY; Lee SG; Lee MK; Kim KL; Hahm KS
Biochem Mol Biol Int; 1997 Oct; 43(3):489-98. PubMed ID: 9352066
[TBL] [Abstract][Full Text] [Related]
17. Selective toxicity of antimicrobial peptide S-thanatin on bacteria.
Wu G; Wu H; Fan X; Zhao R; Li X; Wang S; Ma Y; Shen Z; Xi T
Peptides; 2010 Sep; 31(9):1669-73. PubMed ID: 20600431
[TBL] [Abstract][Full Text] [Related]
18. Melectin MAPs: the influence of dendrimerization on antimicrobial and hemolytic activity.
Niederhafner P; Bednárová L; Buděšínský M; Safařík M; Ehala S; Ježek J; Borovičková L; Fučík V; Ceřovský V; Slaninová J
Amino Acids; 2010 Nov; 39(5):1553-61. PubMed ID: 20499256
[TBL] [Abstract][Full Text] [Related]
19. Characterization of cell selectivity, physiological stability and endotoxin neutralization capabilities of α-helix-based peptide amphiphiles.
Ma Z; Wei D; Yan P; Zhu X; Shan A; Bi Z
Biomaterials; 2015 Jun; 52():517-30. PubMed ID: 25818457
[TBL] [Abstract][Full Text] [Related]
20. New potent antimicrobial peptides from the venom of Polistinae wasps and their analogs.
Cerovský V; Slaninová J; Fucík V; Hulacová H; Borovicková L; Jezek R; Bednárová L
Peptides; 2008 Jun; 29(6):992-1003. PubMed ID: 18375018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
